Antigen-targeted T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Antigen-targeted T cell therapy, covering 2026-04-09 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas [Phase 1, Phase 2]